Variable global distribution of cell-of-origin from the ROBUST phase III study in diffuse large B-cell lymphoma

Authors:

Abstract
The objectives of these analyses were to examine cell-of-origin (COO) subtype distribution from multiple geographical locations globally, and assess the feasibility and efficiency of gene expression profiling (GEP) for patient selection from the ROBUST phase III randomized study of R 2-CHOP vs placebo/R-CHOP in patients with ABC-type diffuse large B-cell lymphoma. Diagnostic evaluation of COO subtype showed notable differences in the proportion of ABC-DLBCL incidences based on geographical origin and GEP analyses demonstrated rapid turnaround time to enable efficient patient classification and enrollment.

This publication has 15 references indexed in Scilit: